Mumbai-based skincare brand Be Clinical has raised ₹6 crore in a seed funding round led by V3 Ventures, with Titan Capital also participating and increasing its earlier commitment.
The brand had previously raised ₹2 crore in the same round led by Titan Capital, along with participation from P-TAL founder Aditya Agarwal.
The fresh capital will be used to strengthen Be Clinical’s in-house research and development capabilities, conduct clinical testing, and build targeted solutions for ageing concerns across the face, body, and scalp.
The company also plans to expand its manufacturing facility by adding advanced machinery to improve production capacity and quality control.
Founded in May 2024 by Hemangi Dhir, Be Clinical is an evidence-led skincare brand focused on clinically tested products developed for Indian skin and environmental conditions. The brand works on in-vivo tested formulations and operates with end-to-end in-house research and manufacturing.
Since launch, Be Clinical claims to have served over 25,000 customers and seen early traction across its direct-to-consumer channels. The company plans to further invest in packaging upgrades designed to preserve ingredient efficacy while supporting its clinical positioning.
Be Clinical operates in the anti-ageing skincare segment, competing with brands such as Olay, Neutrogena, Clinique, and Dr. Sheth, as it continues to build science-backed solutions for the Indian market.
